1WA
WST icon

180 Wealth Advisors’s West Pharmaceutical WST Stock Holding History

180 Wealth Advisors’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-899
Closed -$364K – 409
2021
Q3 		$364K Sell
899
-164
-15% -$69.1K 0.08% 241
2021
Q2 		$452K Buy
+1,063
New +$351K 0.1% 196

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

180 Wealth Advisors's WST Position: Q4 2021 in Review

180 Wealth Advisors sold out of West Pharmaceutical (WST) in Q4 2021, closing a stake of 899 shares — an estimated $364K sold.

180 Wealth Advisors first reported a position in WST in Q2 2021 and held it in 2 quarters. The position peaked at $452K in Q2 2021. 730 funds tracked by Wall St. Rank hold WST as of Q4 2021.

  • 180 Wealth Advisors reported no remaining West Pharmaceutical position as of Q4 2021 after selling out during the quarter.
  • 180 Wealth Advisors sold 899 West Pharmaceutical shares in Q4 2021, an estimated $364K.
  • 180 Wealth Advisors first reported a position in West Pharmaceutical in Q2 2021 and held it in 2 quarters.
  • 180 Wealth Advisors's West Pharmaceutical position peaked at $452K in Q2 2021.
  • 730 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2021.

Based on 180 Wealth Advisors's 13F filing for Q4 2021, filed 26 Jan 2022.